Randomized, Multicenter Phase II Study of Pembrolizumab in Combination With Chemotherapy and Chemoradiation in Locally Advanced Esophageal Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Oesophageal cancer
- Focus Therapeutic Use
- 05 May 2017 Status changed from not yet recruiting to recruiting.
- 01 Mar 2017 Planned initiation date changed from 1 Dec 2016 to 1 Mar 2017.
- 22 Dec 2016 New trial record